The medical concerns of patients with thalassemias at the time of COVID-19 outbreak: The personal experience and the international recommendations

The medical concerns of patients with thalassemias at the time of COVID-19 outbreak: The personal experience and the international recommendations

Authors

  • Duran Canatan Pediatric Hematologist and Geneticist President Mediterranean Blood Diseases Foundation Director of Hemoglobinopathy Diagnosis Center Antalya -Turkey
  • Vincenzo De Sanctis Pediatric and Adolescent Outpatient Clinic, Quisisana Hospital, Ferrara, Italy

Keywords:

.

Abstract

.

References

Shah FT, Sayani F, Trompeter S, Drasar E, Piga A. Challenges of blood transfusions in β-thalassemia. Blood Rev. 2019;37:100588. doi:10.1016/j.blre.2019.100588.

Vidja PJ, Vachhani JH, Sheikh SS, Santwani PM. Blood transfusion transmitted infections in multiple blood transfused patients of Beta thalassaemia. Indian J Hematol Blood Transfus. 2011;27:65–69.

Canatan D. The Thalassemia center of Antalya State Hospital:15 years of experience (1994 to 2008). J Pediatr Hematol Oncol. 2013;35:24–27.

Canatan D. Thalassemias and Hemoglobinopathies in Turkey. Hemoglobin.2014;38:305-307.

de Sanctis V, Ruggiero L, Soliman AT, Daar S, Salvatore Di Maio S, Kattamis C. Coronavirus Disease 2019 ( COVID-19) in adolescents: An update on current clinical and diagnostic characteristics. Submitted for publication to Acta Biomedica. 2020.

Zhao J, Yang Y, Huang H, Li D, Gu D, Lu X , Zhang Z, Liu L, Liu T, Liu Y, He Y, Sun B, Wei M, Yang G, Wang X, Zhang L, Zhou X, Xing M, Wang PG. Relationship between the ABO blood group and the COVID-19 susceptibility. [Accessed on: 23/03/2020.]medRxiv 2020.03.11. 20031096; doi: https://doi.org/10.1101/2020.03.11.20031096.

https://www.redcross.org/about-us/news-and-events/press-release/2020/red-cross-media-statement-on-2019-novel-coronavirus.html.

World Health Organization. Maintaining a safe and adequate blood supply during the pandemic outbreak of coronavirus disease (COVID-19): Interim guidance [20 March 2020].WHO/2019 NCOV/BLOODSUPPLY/2020.1.

World Health Organization. Maintaining a safe and adequate blood supply during pandemic influenza: Guidelines for Blood Transfusion Services. Geneva, Switzerland: World Health Organization; 2011.

Chinese Society of Blood Transfusion [Internet]. Recommendations for blood establishments regarding the novel coronavirus disease (COVID-19) outbreak. Available at: http://eng.csbt.org.cn/ portal/article/index/id/606/cid/7.html. Accessed on: 23/03/2020.

Asian Association of Transfusion Medicine. Recommendations to prevent COVID-19 infection through the blood supply. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public.

Centro Nazionale Sangue [Internet]. [Coronavirus, precautionary measures updated]. Available at: https://www.centronazionalesangue. it/node/831. Accessed on 31/03/2020. [In Italian].

Cai X, Ren M, Chen F, Li L, Lei H, Wang X. Blood transfusion during the COVID-19 outbreak. Blood Transfus. 2020; 18: 79-82.

Mair-Jenkins J, Saavedra-Campos M, Baillie JK, , Cleary P, Fu-Meng Khaw FM, Wei Shen Lim WS, Sophia Makki S, Kevin D Rooney K, Nguyen-Van-Tam J S, Beck CR, Convalescent Plasma Study Group. Convalescent Plasma Study Group.The effectiveness of convalescent plasma and

hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J Infect Dis 2015; 211: 80-90.

Mair-Jenkins J, Saavedra-Campos M, Baillie JK, , Cleary P, Fu-Meng Khaw FM, Wei Shen Lim WS, Sophia Makki S, Kevin D Rooney K, Nguyen-Van-Tam J S, Beck CR, Convalescent Plasma Study Group. Convalescent Plasma Study Group.The effectiveness of convalescent plasma and

hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J Infect Dis. 2015; 211: 80-90.

World Health Organization. Maintaining a safe and adequate blood supply during the pandemic outbreak of coronavirus disease (COVID-19): Interim guidance [20 March 2020].WHO/2019 NCOV/BLOODSUPPLY/2020.1.

Downloads

Published

11-05-2020

Issue

Section

CORRESPONDENCE - SPECIAL COVID19

How to Cite

1.
Canatan D, De Sanctis V. The medical concerns of patients with thalassemias at the time of COVID-19 outbreak: The personal experience and the international recommendations . Acta Biomed [Internet]. 2020 May 11 [cited 2024 Jul. 21];91(2):218-21. Available from: https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/9533